(redirected from End-stage renal disease)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to End-stage renal disease: kidney disease
References in periodicals archive ?
Pervasis believes its proprietary cellular therapy may become the standard of care to promote natural healing following any vascular intervention, including AV access creation for patients with end-stage renal disease, peripheral and coronary bypass, angioplasty and stent placement.
We believe that, upon its approval, Nephros' technology will be a vitally important addition to the physician's arsenal in treating patients with End-Stage Renal Disease, providing potentially substantial reductions in patient morbidity, mortality, and overall treatment costs.
We are excited about this new partnership with Empire and look forward to helping coordinate the care of plan members with end-stage renal disease," said John Dickmeyer, M.
Due to a lack of transplant organs, the vast majority of end-stage renal disease patients must go on dialysis.
CareMore Reliance is for seniors living with the challenges of chronic illness such as diabetes, hypertension, chronic obstructive pulmonary disease or end-stage renal disease.
The trials were designed to study the safety of Vascugel[TM] in maintaining vascular patency in patients with arteriovenous access fistulas (AVF) and arteriovenous access grafts (AVG) for dialysis treatment of end-stage renal disease (ESRD).
BOSTON -- TA Associates, a leading buyout and private equity firm, today announced the completion of a $130 million minority leveraged recapitalization of American Access Care (AAC), a rapidly growing operator of outpatient vascular access centers serving individuals with end-stage renal disease (ESRD), commonly known as kidney failure.
Patients with end-stage renal disease do not produce adequate amounts of erythropoietin and consequently suffer from the energy-draining signs and symptoms of chronic anemia.
Matria manages major chronic diseases and episodic conditions including diabetes, congestive heart failure, coronary artery disease, asthma, chronic obstructive pulmonary disease, high-risk obstetrics, cancer, chronic pain, depression, end-stage renal disease, and obesity; delivers programs that address wellness, healthy living, productivity improvement, and patient advocacy; and provides case management of acute and catastrophic conditions.
PhosLo is a calcium acetate phosphate binder for oral application in end-stage renal disease patients that has total product line revenues in the U.